We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies on the site. Please see our Privacy Policy for details.

Why a Surgical Divestiture May Not Be Enough

Corporate CounselMarch 22, 2017

Summary

Jon Dubrow and Gregory Heltzer wrote this bylined article describing how government antitrust regulators have recently rejected surgical divestitures or other proposed remedies in business combinations. Recent failed deals show that the DOJ and FTC “have continued to raise the bar for what they view as acceptable remedies and buyers,” the authors wrote.